These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 536286)

  • 21. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    Brown BS
    J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of excitability to conduction velocity in canine Purkinje tissue.
    Peon J; Ferrier GR; Moe GK
    Circ Res; 1978 Jul; 43(1):125-35. PubMed ID: 657454
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiological mechanisms underlying rate-dependent changes of refractoriness in normal and segmentally depressed canine Purkinje fibers. The characteristics of post-repolarization refractoriness.
    Davidenko JM; Antzelevitch C
    Circ Res; 1986 Feb; 58(2):257-68. PubMed ID: 3948343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiological effects of norepinephrine on slow responses induced in isolated canine cardiac Purkinje fibers by reduced extracellular pH.
    Davis LD; Helmer PR
    J Pharmacol Exp Ther; 1980 Jul; 214(1):94-100. PubMed ID: 7391976
    [No Abstract]   [Full Text] [Related]  

  • 25. Recovery from use-dependent block of Vmax and restitution of action potential duration in canine cardiac Purkinje fibers.
    Elharrar V
    J Pharmacol Exp Ther; 1988 Jul; 246(1):235-42. PubMed ID: 3392655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Voltage- and rate-dependent depression of Vmax of action potentials by a new antiarrhythmic agent, E-0747, in swine cardiac Purkinje fibers.
    Sawada K; Shoji T; Igarashi T; Hiraoka M
    J Cardiovasc Pharmacol; 1987 Jan; 9(1):51-6. PubMed ID: 2434794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of acidosis and bicarbonate on action potential repolarization in canine cardiac Purkinje fibers.
    Spitzer KW; Hogan PM
    J Gen Physiol; 1979 Feb; 73(2):199-218. PubMed ID: 438770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On-line analysis of intracellular electrophysiological data using a microcomputer system.
    Elharrar V; Lovelace DE
    Am J Physiol; 1979 Sep; 237(3):H400-8. PubMed ID: 474778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcholine lengthens action potentials of sheep cardiac Purkinje fibers.
    Lipsius SL; Gibbons WR
    Am J Physiol; 1980 Feb; 238(2):H237-43. PubMed ID: 7361920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cycle-length alteration on canine cardiac action potentials.
    Greenspan K; Edmands RE; Fisch C
    Am J Physiol; 1967 Jun; 212(6):1416-20. PubMed ID: 4952133
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers.
    Nattel S; Zeng FD
    J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electrophysiological actions of BRB-I-28 in canine myocardial tissues.
    Patterson E; Scherlag BJ; Berlin KD; Lazzara R
    J Pharmacol Exp Ther; 1991 Nov; 259(2):558-65. PubMed ID: 1941607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrical uncoupling and impulse propagation in isolated sheep Purkinje fibers.
    Jalife J; Sicouri S; Delmar M; Michaels DC
    Am J Physiol; 1989 Jul; 257(1 Pt 2):H179-89. PubMed ID: 2750935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of tetracyclic antidepressant drugs on the electrophysiological properties of canine cardiac Purkinje fibres.
    Brennan FJ; Cassidy DM
    Can J Cardiol; 1988 Sep; 4(6):281-6. PubMed ID: 3179792
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiologic actions and interactions between lysophosphatidylcholine and lidocaine in the nonsteady state: the match between multiphasic arrhythmogenic mechanisms and multiple drug effects in cardiac Purkinje fibers.
    Sawicki GJ; Arnsdorf MF
    J Pharmacol Exp Ther; 1985 Dec; 235(3):829-38. PubMed ID: 4078734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Excitability and oscillatory afterpotentials in isolated sheep cardiac Purkinje fibers.
    Terek RM; January CT
    Am J Physiol; 1987 Mar; 252(3 Pt 2):H645-52. PubMed ID: 3826406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers.
    Nattel S
    J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the potassium channel activator, BRL 34915, on the action potential characteristics of canine cardiac Purkinje fibers.
    Bril A; Man RY
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1090-6. PubMed ID: 2359018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction of Vmax by QX-314 and benzocaine in neonatal and adult canine cardiac Purkinje fibers.
    Spinelli W; Danilo P; Rosen MR
    J Pharmacol Exp Ther; 1988 Apr; 245(1):381-7. PubMed ID: 3361451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the maximum frequency components and digital sampling of cardiac Purkinje fiber action potentials.
    Buckles DS; Hewett KW
    Comput Biomed Res; 1986 Oct; 19(5):410-6. PubMed ID: 3769469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.